Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
To demonstrate comparable safety and efficacy of Taro Pharmaceuticals Inc. butenafine
hydrochloride cream 1% (test product) and Lotrimin Ultra® cream (reference listed drug) in
the treatment of interdigital tinea pedis, and to show the superiority of the active
treatments over that of the placebo (vehicle).